NIHR CLAHRC South West Peninsula (PenCLAHRC), University of Exeter Medical School, Exeter.
Bristol Royal Hospital for Children, Bristol.
J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):23-33. doi: 10.1097/MPG.0000000000001922.
Between 4% and 25% of school-aged children complain of recurrent abdominal pain (RAP) severe enough to interfere with their daily activities.
We carried out a systematic review of randomised controlled trials (RCTs) in eleven databases and 2 trials registries from inception to June 2016. An update search was run in November 2017. All screening was performed by 2 independent reviewers. Included studies were appraised using the Cochrane risk of bias tool and the evidence assessed using GRADE. We included any dietary, pharmacological or psychosocial intervention for RAP, defined by Apley or an abdominal pain-related functional gastrointestinal disorder, as defined by the Rome III criteria, in children and adolescents.
We included 55 RCTs, involving 3572 children with RAP (21 dietary, 15 pharmacological, 19 psychosocial, and 1 multiarm). We found probiotic diets, cognitive-behavioural therapy (CBT) and hypnotherapy were reported to reduce pain in the short-term and there is some evidence of medium term effectiveness. There was insufficient evidence of effectiveness for all other dietary interventions and psychosocial therapies. There was no robust evidence of effectiveness for pharmacological interventions.
Overall the evidence base for treatment decisions is poor. These data suggest that probiotics, CBT, and hypnotherapy could be considered as part of holistic management of children with RAP. The evidence regarding relative effectiveness of different strains of probiotics is currently insufficient to guide clinical practice. The lack of evidence of effectiveness for any drug suggests that there is little justification for their use outside of well-conducted clinical trials. There is an urgent need for high-quality RCTs to provide evidence to guide management of this common condition.
4%至 25%的学龄儿童会抱怨反复发作的腹痛(RAP),其严重程度足以干扰他们的日常活动。
我们对从开始到 2016 年 6 月的 11 个数据库和 2 个试验登记处的随机对照试验(RCT)进行了系统评价。2017 年 11 月进行了更新搜索。所有筛选均由 2 名独立审查员进行。使用 Cochrane 偏倚风险工具评估纳入研究,并使用 GRADE 评估证据。我们纳入了任何饮食、药理学或心理社会干预 RAP 的研究,RAP 由 Apley 定义或由罗马 III 标准定义的与腹痛相关的功能性胃肠疾病定义,纳入的研究对象为儿童和青少年。
我们纳入了 55 项 RCT,涉及 3572 名 RAP 儿童(21 项饮食干预、15 项药物干预、19 项心理社会干预和 1 项多臂干预)。我们发现益生菌饮食、认知行为疗法(CBT)和催眠疗法在短期报告中可减轻疼痛,并且具有一定的中期疗效证据。所有其他饮食干预和心理社会治疗的有效性证据不足。药物干预的有效性证据不足。
总体而言,治疗决策的证据基础较差。这些数据表明,益生菌、CBT 和催眠疗法可作为 RAP 儿童整体管理的一部分。目前,关于不同益生菌菌株相对有效性的证据不足,无法指导临床实践。任何药物都没有疗效的证据表明,除了经过良好设计的临床试验之外,它们的使用没有什么正当理由。迫切需要高质量的 RCT 提供证据,以指导这种常见疾病的管理。